307 related articles for article (PubMed ID: 22891333)
21. Mitochondrial genome instability in human cancers.
Bianchi NO; Bianchi MS; Richard SM
Mutat Res; 2001 Mar; 488(1):9-23. PubMed ID: 11223402
[TBL] [Abstract][Full Text] [Related]
22. Uncovering the profile of somatic mtDNA mutations in Chinese colorectal cancer patients.
Wang CY; Li H; Hao XD; Liu J; Wang JX; Wang WZ; Kong QP; Zhang YP
PLoS One; 2011; 6(6):e21613. PubMed ID: 21738732
[TBL] [Abstract][Full Text] [Related]
23. Somatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancer.
Hung WY; Wu CW; Yin PH; Chang CJ; Li AF; Chi CW; Wei YH; Lee HC
Biochim Biophys Acta; 2010 Mar; 1800(3):264-70. PubMed ID: 19527772
[TBL] [Abstract][Full Text] [Related]
24. Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion.
Lee HC; Hsu LS; Yin PH; Lee LM; Chi CW
Mitochondrion; 2007; 7(1-2):157-63. PubMed ID: 17280876
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial DNA mutations in Malaysian female breast cancer patients.
Omasanggar R; Yu CY; Ang GY; Emran NA; Kitan N; Baghawi A; Falparado Ahmad A; Abdullah MA; Teh LK; Maniam S
PLoS One; 2020; 15(5):e0233461. PubMed ID: 32442190
[TBL] [Abstract][Full Text] [Related]
26. Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA.
Gorelick AN; Kim M; Chatila WK; La K; Hakimi AA; Berger MF; Taylor BS; Gammage PA; Reznik E
Nat Metab; 2021 Apr; 3(4):558-570. PubMed ID: 33833465
[TBL] [Abstract][Full Text] [Related]
27. Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors.
De Vitto H; Mendonça BS; Elseth KM; Vesper BJ; Portari EA; Gallo CV; Paradise WA; Rumjanek FD; Radosevich JA
Tumour Biol; 2013 Feb; 34(1):337-47. PubMed ID: 23238816
[TBL] [Abstract][Full Text] [Related]
28. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
29. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.
Wong KK; Bateman NW; Ng CW; Tsang YTM; Sun CS; Celestino J; Nguyen TV; Malpica A; Hillman RT; Zhang J; Futreal PA; Rojas C; Conrads KA; Hood BL; Dalgard CL; Wilkerson MD; Phippen NT; Conrads TP; Maxwell GL; Sood AK; Gershenson DM
J Transl Med; 2022 Dec; 20(1):606. PubMed ID: 36528667
[TBL] [Abstract][Full Text] [Related]
30. Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.
Li X; Guo X; Li D; Du X; Yin C; Chen C; Fang W; Bian Z; Zhang J; Li B; Yang H; Xing J
Int J Cancer; 2018 Sep; 143(5):1143-1152. PubMed ID: 29569724
[TBL] [Abstract][Full Text] [Related]
31. Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates.
McMahon S; LaFramboise T
Carcinogenesis; 2014 May; 35(5):1046-54. PubMed ID: 24442641
[TBL] [Abstract][Full Text] [Related]
32. The pattern of natural selection in somatic cancer mutations of human mtDNA.
Stafford P; Chen-Quin EB
J Hum Genet; 2010 Sep; 55(9):605-12. PubMed ID: 20613764
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.
Link DC; Schuettpelz LG; Shen D; Wang J; Walter MJ; Kulkarni S; Payton JE; Ivanovich J; Goodfellow PJ; Le Beau M; Koboldt DC; Dooling DJ; Fulton RS; Bender RH; Fulton LL; Delehaunty KD; Fronick CC; Appelbaum EL; Schmidt H; Abbott R; O'Laughlin M; Chen K; McLellan MD; Varghese N; Nagarajan R; Heath S; Graubert TA; Ding L; Ley TJ; Zambetti GP; Wilson RK; Mardis ER
JAMA; 2011 Apr; 305(15):1568-76. PubMed ID: 21505135
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial variants in MT-CO2 and D-loop instability are involved in MUTYH-associated polyposis.
Errichiello E; Balsamo A; Cerni M; Venesio T
J Mol Med (Berl); 2015 Nov; 93(11):1271-81. PubMed ID: 26138249
[TBL] [Abstract][Full Text] [Related]
35. Spectrum of mitochondrial genomic variation in parathyroid neoplasms.
Hu Y; Zhang X; Wang O; Xing X; Cui M; Wang M; Song C; Liao Q
Endocrine; 2021 Dec; 74(3):690-697. PubMed ID: 34296389
[TBL] [Abstract][Full Text] [Related]
36. Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.
Pereira L; Soares P; Máximo V; Samuels DC
BMC Cancer; 2012 Feb; 12():53. PubMed ID: 22299657
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutation of IL7R exon 6 in acute leukemias and solid cancers.
Kim MS; Chung NG; Kim MS; Yoo NJ; Lee SH
Hum Pathol; 2013 Apr; 44(4):551-5. PubMed ID: 23069254
[TBL] [Abstract][Full Text] [Related]
38. The mtDNA mutation spectrum in the PolG mutator mouse reveals germline and somatic selection.
Maclaine KD; Stebbings KA; Llano DA; Havird JC
BMC Genom Data; 2021 Nov; 22(1):52. PubMed ID: 34823474
[TBL] [Abstract][Full Text] [Related]
39. Next-generation sequencing reveals mitogenome diversity in plasma extracellular vesicles from colorectal cancer patients.
Bjørnetrø T; Bousquet PA; Redalen KR; Trøseid AS; Lüders T; Stang E; Sanabria AM; Johansen C; Fuglestad AJ; Kersten C; Meltzer S; Ree AH
BMC Cancer; 2023 Jul; 23(1):650. PubMed ID: 37438741
[TBL] [Abstract][Full Text] [Related]
40. Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors.
Kurtz A; Lueth M; Kluwe L; Zhang T; Foster R; Mautner VF; Hartmann M; Tan DJ; Martuza RL; Friedrich RE; Driever PH; Wong LJ
Mol Cancer Res; 2004 Aug; 2(8):433-41. PubMed ID: 15328370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
